Registre National des Cancers de l’Enfant

Diagnostic groups and subgroups AAPC(%) 95%CI p
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases 0.1 [-0.4;0.7] 0.64
I.a Lymphoid leukemias 0.4 [-0.2;1.0] 0.23
I.b Acute myeloid leukemias -0.6 [-2.0;0.8] 0.38
II. Lymphomas and reticuloendothelial neoplasms -1.1 [-1.9;-0.2] 0.02
II.a Hodgkin lymphomas -0.3 [-1.6;0.9] 0.59
II.b Non-Hodgkin lymphomas (except Burkitt lymphomas) -1.2 [-2.7;0.3] 0.13
II.c Burkitt lymphomas -2.2 [-3.8;-0.5] 0.01
III. CNS and miscellaneous intracranial and intraspinal neoplasms 0.4 [-0.1;1.0] 0.13
III.a Ependymomas and choroid plexus tumors 0.8 [-1.0;2.6] 0.39
III.b Astrocytomas 0.5 [-0.4;1.4] 0.30
III.c Intracranial and intraspinal embryonal tumors -0.9 [-2.2;0.4] 0.17
III.d Other gliomas 0.1 [-1.4;1.7] 0.87
III.e Other specified intracranial and intraspinal neoplasms 2.0 [0.6;3.4]  <0.01
IV. Neuroblastomas and other peripheral nervous cell tumors -0.4 [-1.3;0.6] 0.48
IV.a Neuroblastomas and ganglioneuroblastomas -0.4 [-1.4;0.6] 0.40
V. Retinoblastomas -0.7 [-2.4;0.9] 0.40
VI. Renal tumors -0.2 [-1.3;1.0] 0.77
VI.a Nephroblastomas and other nonepithelial renal tumors -0.1 [-1.3;1.2] 0.92
VII. Hepatic tumors 2.0 [-0.8;4.9] 0.16
VII.a Hepatoblastomas 1.9 [-1.2;5.1] 0.23
VIII. Malignant bone tumors -0.4 [-1.7;0.9] 0.53
VIII.a Osteosarcomas -0.9 [-2.8;1.0] 0.35
VIII.c Ewing tumors and related bone sarcomas 0.7 [-1.2;2.7] 0.47
IX. Soft tissue and other extraosseous sarcomas -0.1 [-1.2;1.0] 0.80
IX.a Rhabdomyosarcomas 0.1 [-1.4;1.6] 0.88
IX.b Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms -0.3 [-4.4;3.9] 0.89
IX.d Other specified soft tissue sarcomas -0.5 [-2.4;1.5] 0.65
IX.e Unspecified soft tissue sarcomas 0.1 [-3.9;4.3] 0.95
X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads -1.5 [-2.9;-0.1] 0.04
X.a Intracranial and intraspinal germ cell tumors -0.5 [-2.8;1.9] 0.67
X.b Malignant extracranial and extragonadal germ cell tumors -1.8 [-4.5;1.0] 0.21
X.c Malignant gonadal germ cell tumors -2.6 [-5.0;-0.1] 0.04
XI. Other malignant epithelial neoplasms and malignant melanomas 1.2 [-0.4;2.7] 0.14
XI.b Thyroid carcinomas -0.8 [-3.1;1.6] 0.53
XI.d Malignant melanomas -0.9 [-4.4;2.7] 0.62
XII. Other and unspecified malignant neoplasms 3.6 [-2.6;10.1] 0.26
All cancers (excluding LCH) -0.1 [-0.3;0.2] 0.72
Langherhans cell histiocytosis (LCH) -1.3 [-5.6;3.2] 0.56
All cancers (including LCH) -0.1 [-0.3;0.2] 0.69

AAPC: average annual percent change in incidence rate (estimated by Poisson regression model)

Temporal variations in the incidence rate of childhood cancer in mainland France, 2000-2014

Villejuif

INSERM
UMRS1153 Equipe 7
Bâtiment 15/16
16 avenue Paul Vaillant Couturier
94807 Villejuif Cedex

+33 (0)1 45 59 50 37
rnhe@inserm.fr

Nancy

Faculté de Médecine
BP 20199
9 avenue de la Forêt de Haye
54505 Vandoeuvre les Nancy Cedex

+33 (0)3 72 74 63 26
rntse@inserm.fr